Neurovascular Orofacial Pain
Orofacial Migraine
Your pain sits in the temple, the jaw, around the eye — so you went to the dentist. Maybe a splint, maybe endodontics. But the pain pulses, light bothers you, and nothing dental has helped. Migraine can present in the face — and treating it as a jaw problem is why it never resolves.
Symptom Profile
The Orofacial Migraine Presentation
- Unilateral, pulsating or throbbing pain in the temple, periorbital region, maxilla, or mandible — often misattributed to dental or TMJ origin
- Moderate to severe intensity with exacerbation by routine physical activity or head movement
- Duration of 4 to 72 hours (untreated), distinguishing migraine from shorter paroxysmal neuralgiform conditions
- Associated symptoms: nausea, photophobia, phonophobia, osmophobia, or aura (visual disturbances, sensory changes)
- Referred pain patterns into the masseter, temporalis, and cervical musculature that mimic myofascial pain
- Allodynia of the scalp, face, or periorbital region during attacks — a marker of central sensitization
- Trigger identification: hormonal fluctuations, sleep disruption, dietary factors, weather changes, or stress
The overlap with TMD is real — both can produce temple, cheek, and periorbital pain. The tell is migraine's neurological signature: pulsating quality, nausea, light and sound sensitivity. Those features point to a neurovascular cause.
Migraine-like pain that no migraine treatment has touched? The trigeminal system may be the real source. Dr. Chung's 60–90 minute diagnostic consultation is built to find it.
Pathophysiology
The Neurovascular Mechanism
Migraine is a neurovascular event: a wave of brain activity activates the trigeminovascular system and releases CGRP, a chemical that inflames and dilates the pain-serving vessels. The trigeminal nerve supplies the face and jaw as well as those structures — which is why the pain can land below the eye and in the jaw instead of the classic half-head pattern.
Key Neurovascular Features
- Cortical spreading depression — the wave that precedes aura and ignites the migraine cascade
- Trigeminovascular activation — the pain fibers serving both head and face fire together
- CGRP release — the chemical amplifier of neurogenic inflammation
- Central sensitization — chronic attacks lower the pain threshold in the face itself
Migraine vs. TMD: Why the Distinction Matters
- Migraine is treated with triptans, CGRP antagonists, and preventives — not occlusal splints
- TMD treatment will not resolve migraine — and vice versa
- The two are frequently comorbid; the dominant driver must be identified to prioritize treatment
- Neurological features — aura, photophobia, nausea — shift the classification toward neurovascular
Diagnostic Taxonomy
ICHD-3 Classification: Migraine with Orofacial Involvement
The international headache classification (ICHD-3) provides the diagnostic framework — and orofacial migraine lives inside it:
1. Migraine Without Aura (ICHD-3 1.1)
Recurrent headache attacks lasting 4–72 hours, unilateral, pulsating quality, moderate to severe intensity, aggravated by physical activity, with nausea and/or photophobia and phonophobia. When the pain distribution involves the temple, maxilla, or mandible, this is the most common orofacial migraine presentation.
2. Migraine With Aura (ICHD-3 1.2)
Migraine attacks preceded by reversible focal neurological symptoms — most commonly visual (scintillating scotoma, fortification spectra). Aura symptoms develop gradually over 5 minutes and last 5–60 minutes. Orofacial pain follows the aura phase in the same distribution.
3. Chronic Migraine (ICHD-3 1.3)
Headache occurring on 15 or more days per month for more than three months, with at least eight of those days meeting migraine criteria. Chronic migraine often presents with continuous or near-continuous orofacial pain and is associated with medication overuse and central sensitization.
4. Probable Migraine (ICHD-3 1.6)
Headache attacks that meet all but one of the criteria for migraine without aura. Commonly encountered in orofacial presentations where patients describe the characteristic features but the clinical picture is incomplete — requiring careful classification and monitoring for evolution to definite migraine.
5. Headache Attributed to TMD (ICHD-3 11.7)
Headache caused by a disorder of the temporomandibular joint or masticatory muscles, with evidence of causation demonstrated by clinical examination and imaging. This diagnostic code exists specifically for the migraine-TMD overlap — it classifies headache that is genuinely TMD-attributed rather than migraine-referred.
Clinical Protocol
Diagnostic Approach
Full ICHD-3 assessment — pain character, duration, triggers, aura, and diary review with validated screening instruments.
TMJ testing, muscle palpation, cervical and cranial nerve assessment — mapping referral patterns to separate neurovascular from musculoskeletal.
One of four answers: migraine with orofacial involvement, TMD with headache, tension-type with facial referral, or genuine dual pathology.
Neurovascular treatment for migraine; musculoskeletal treatment for TMD; a combined plan when both are confirmed.
Frequently Asked Questions
Orofacial Migraine: Common Questions
How is orofacial migraine different from TMJ pain?
Orofacial migraine is one-sided, pulsating pain lasting 4–72 hours with neurological features — light sensitivity, nausea, aura. TMJ pain is musculoskeletal: it tracks jaw movement, joint sounds, and muscle tenderness. The treatments are opposites, which is why the distinction matters.
Why does my migraine pain occur in my jaw and face rather than my head?
The trigeminal nerve serves the face, jaw, and mouth as well as the structures inside the head involved in migraine. During an attack, the released chemicals inflame those pathways, and the pain lands in the temple, around the eye, and in the upper jaw — exactly where TMJ and dental pain also land.
Can migraine and TMD occur at the same time?
Yes — frequently. Migraine sensitizes the orofacial region, and jaw-muscle tension can trigger migraine attacks. When both coexist, the dominant driver has to be identified first, and treatment may need to address both mechanisms at once.
What is CGRP and how does it relate to orofacial migraine?
CGRP is a chemical released during migraine attacks that drives neurogenic inflammation and pain signaling. The newer CGRP-targeted therapies — monoclonal antibodies and gepants — address the mechanism directly and have become central to migraine treatment.
Will a TMJ splint help with orofacial migraine?
If the pain is genuinely migraine, no — a splint treats mechanics, not neurovascular pathways. But when a real TMD component rides along with migraine, the splint can reduce that contribution. Classification first; splint second.
If your orofacial pain has been treated as a dental or TMJ condition without resolution, and you experience pulsating head or facial pain with light sensitivity, sound sensitivity, or nausea, a neurovascular classification should be considered.
No referral needed · Help filing with medical insurance · $650